Senti Biosciences Holdings, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Timothy Lu (CEO) and Jay Cross (CFO) certified the June 30, 2026 quarterly report on August 14, 2026, confirming accuracy of financial statements and effectiveness of disclosure controls and internal controls per Sarbanes-Oxley Sections 302 and 906. No material weaknesses, deficiencies, or fraud disclosures were reported. This is a routine certification exhibit with no business or financial events disclosed.
Why this rating
Standard SOX-mandated executive certification; no substantive business, financial, or operational information disclosed. Purely procedural compliance filing.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.